Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05739591 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-term Safety and Efficacy of GBG Study Participants

Name: Long-term Safety and Efficacy of GBG Study Participants — clinical trial record (NCT05739591)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ETERNITY

StatusRecruiting

PhaseNot specified

SponsorGBG Forschungs GmbH

Started2022-10-12

View on ClinicalTrials.gov ↗

Amendment history

2026-09-16

Trial sites expanded: 3 → 23 locations

2024-10-01

Study Status, Contacts/Locations v1

Re-verified, no change to tracked fields

2023-02-20

Original filing

GBG Forschungs GmbH

5 trials monitored

See 1 trial at risk

Breast Cancer

5,180 trials monitored

See 256 trials at risk

The ETERNITY study is an international, multicenter, observational study that aims to follow up patients who have participated in a GBG trial for early breast cancer, even after the study has officially ended, in order to collect long-term data on survival, late or delayed adverse events, in addition to information related to pregnancy, fertility and other parameters impacting quality of life.

Trial Details

NCT Number	NCT05739591
Lead Sponsor	GBG Forschungs GmbH
Conditions	Breast Cancer
Enrollment	400 participants
Start Date	2022-10-12
Primary Completion	2030-05-19 (estimated)
Study Completion	2030-05-19 (estimated)
Updated on ClinicalTrials.gov	2026-09-15